IPCA LABORATORIES
Back to Cashflow Statement
|
IPCA LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-754 Cr | ₹-283 Cr | ₹-553 Cr | ₹507 Cr | ₹427 Cr |
What is the latest Cash Flow from Financing Activities ratio of IPCA LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-754 Cr |
| Mar2025 | ₹-283 Cr |
| Mar2024 | ₹-553 Cr |
| Mar2023 | ₹507 Cr |
| Mar2022 | ₹427 Cr |
How is Cash Flow from Financing Activities of IPCA LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-754 Cr | Negative | |
| Mar2025 | ₹-283 Cr | Negative | |
| Mar2024 | ₹-553 Cr | Negative | |
| Mar2023 | ₹507 Cr | 18.85 | |
| Mar2022 | ₹427 Cr | - | |
Compare Cash Flow from Financing Activities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,466.4 Cr | 1.2% | 0.2% | 53.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 1.2% |
0.2% |
53.1% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses